Claims
- 1. A method for providing contraception to a woman of childbearing age, wherein the method comprises: administering orally to the woman a dosage form comprising an internal composition comprising a pharmaceutically-acceptable estrogenically-active contraception-regulating steroid, and an overcoat comprising a pharmaceutically-acceptable progestationally-active contraception-regulating steroid, and wherein the method is characterized by the dosage form delivering orally the estrogenically-active steroid in a controlled dose of 0.2 micrograms to 30 micrograms per hour over an extended period up to 24 hours for contraceptive control, compared to a dosage form that delivers an estrogenically-active steroid in an uncontrolled dose, and the progestationally-active steroid is delivered in a dose of 10 nanograms to 150 milligrams in an instantly released dose of from zero to sixty minutes from the dosage form overcoat to provide contraception.
- 2. A method for providing contraception to a woman of childbearing age, wherein the method comprises: administering orally to the woman a dosage from comprising an overcoat comprising 10 nanograms to 25 milligrams of a pharmaceutically acceptable estrogenically-active contraception-regulating steroid and 15 nanograms to 150 milligrams of a pharmaceutically-acceptable progestationally-active contraception-regulating steroid that are delivered in an instantly released dose of from zero to sixty minutes from the dosage form overcoat to provide contraception.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of application Ser. No. 08/037,056, filed Mar. 25, 1993, and benefit of the filing date of said earlier filed application is claimed under 35 U.S.C. .sctn.120, and a continuation of U.S. Ser. No. 07/805,241, filed on Dec. 9, 1991, now U.S. Pat. No. 5,200,197, which application Ser. No. 07/805,241 is a division of U.S. Ser. No. 07/437,480 filed on Nov. 16, 1989, and issued as U.S. Pat. No. 5,098,714 on Mar. 24, 1992, which applications are incorporated herein by reference, and benefit is claimed of their filing date. These applications are assigned to the ALZA Corporation of Palo Alto, Calif.
US Referenced Citations (31)
Foreign Referenced Citations (1)
Number |
Date |
Country |
2166051 |
Apr 1986 |
GBX |
Non-Patent Literature Citations (4)
Entry |
Wurster, Dale E., J. Am. Pharm. Assn., Sci. Ed., vol. 49 (1960) pp. 82-84. |
Wurster, Dale E., J. Am. Pharm. Assn., Sci. Ed., vol. 48 (1959) pp. 451-454. |
The Pharmacological Basis of Therapeutics, Goodman & Gilman, 7th Ed. (1985) pp. 1430-1439. |
Pharmaceutical Sciences, Remington, 14th Ed. (1970) pp. 1626-1680. |
Related Publications (1)
|
Number |
Date |
Country |
|
805241 |
Dec 1991 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
437480 |
Nov 1989 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
37056 |
Mar 1993 |
|